KRIYA ONCOLOGY Trademark Information
Number:
2297410
Ir number:
1680795
Words:
KRIYA ONCOLOGY
Kind:
Word
Status group:
REMOVED
Status code:
Cancelled
Status detail:
Cancelled at the request of IB
Priority date:
11 Jan 2022
Lodgement date:
11 Jul 2022
Ir notification date:
01 Sep 2022
Ir renewal due date:
11 Jul 2032
First report date:
07 Sep 2022
Acceptance date:
07 Sep 2022
Acceptance advertised date:
07 Sep 2022
Entered on register date:
14 Nov 2022
Registered from date:
11 Jul 2022
Registration advertised date:
14 Nov 2022
Renewal due date:
11 Jul 2032
Filing date:
11 Jul 2022
Ir contact:
, , Monica Riva Talley STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C., , Array
Indexing constituents:
KRIYA, ONCOLOGYClass:
5,42
Convention details:
Array
Mark categories:
Trademark
Registration date:
2022-11-14
Last status check:
2026-06-19 21:22:42
Status updated at:
2026-06-19 21:22:42
Goods and services:
1) Class: 5Description: Pharmaceutical preparations for gene therapy, pharmaceutical preparations for the treatment of chronic diseases or cancer, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders.
2) Class: 42
Description: Testing, inspection, research, or development of pharmaceutical preparations for gene therapy, research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases or cancer, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders.
History and publication details:
1) Date: 2025-02-12
Display name: Status change to Voided
2) Date: 2022-11-15
Display name: International Registration in Australia Protected correspondence sent
3) Date: 2022-11-14
Display name: IP Right Registration Published
4) Date: 2022-11-14
Display name: Status change to Registered/Protected
5) Date: 2022-09-08
Display name: Application Accepted correspondence sent
6) Date: 2022-09-07
Display name: IP Right has been Examined
7) Date: 2022-09-07
Display name: IP Right Acceptance Published
8) Date: 2022-09-07
Display name: Status change to Accepted
9) Date: 2022-09-07
Display name: Examination expedited
10) Date: 2022-09-07
Display name: Awaiting examination
11) Date: 2022-09-01
Display name: IP Right Filed Published
12) Date: 2022-09-01
Display name: Status change to Published
13) Date: 2022-09-01
Display name: Status change to Filed
14) Date: 2022-09-01
Display name: Application Received
15) Date: 2022-09-01
Display name: IP right goods and service classes updated
Description: Class Count: 2 Class Numbers:5; 42
Previous details: Class Count: 0 Class Numbers:
New details: Class Count: 2 Class Numbers: 5; 42
16) Date: 2022-09-01
Display name: IP Right Goods and Services Items updated
Description: Class Number: 5
Previous details:
New details: Class Number: 5 Class Items: Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases or cancer, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders.
17) Date: 2022-09-01
Display name: IP Right Goods and Services Items updated
Description: Class Number: 42
Previous details:
New details: Class Number: 42 Class Items: Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases or cancer, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders.
18) Date: 2022-09-01
Display name: Status change to Received
19) Date: 2022-09-01
Display name: Trade mark representation updated
Display name: Status change to Voided
2) Date: 2022-11-15
Display name: International Registration in Australia Protected correspondence sent
3) Date: 2022-11-14
Display name: IP Right Registration Published
4) Date: 2022-11-14
Display name: Status change to Registered/Protected
5) Date: 2022-09-08
Display name: Application Accepted correspondence sent
6) Date: 2022-09-07
Display name: IP Right has been Examined
7) Date: 2022-09-07
Display name: IP Right Acceptance Published
8) Date: 2022-09-07
Display name: Status change to Accepted
9) Date: 2022-09-07
Display name: Examination expedited
10) Date: 2022-09-07
Display name: Awaiting examination
11) Date: 2022-09-01
Display name: IP Right Filed Published
12) Date: 2022-09-01
Display name: Status change to Published
13) Date: 2022-09-01
Display name: Status change to Filed
14) Date: 2022-09-01
Display name: Application Received
15) Date: 2022-09-01
Display name: IP right goods and service classes updated
Description: Class Count: 2 Class Numbers:5; 42
Previous details: Class Count: 0 Class Numbers:
New details: Class Count: 2 Class Numbers: 5; 42
16) Date: 2022-09-01
Display name: IP Right Goods and Services Items updated
Description: Class Number: 5
Previous details:
New details: Class Number: 5 Class Items: Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases or cancer, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders.
17) Date: 2022-09-01
Display name: IP Right Goods and Services Items updated
Description: Class Number: 42
Previous details:
New details: Class Number: 42 Class Items: Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases or cancer, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders.
18) Date: 2022-09-01
Display name: Status change to Received
19) Date: 2022-09-01
Display name: Trade mark representation updated
Owner Information
Owner structured address:
1100 Island Drive, Suite 203 Redwood City CA 94065, UNITED STATES OF AMERICA
Owner is private:
0